EFSCE
BCRX icon

Enterprise Financial Services Corp (EFSC)’s BioCryst Pharmaceuticals BCRX Stock Holding History

Enterprise Financial Services Corp (EFSC)’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-118
Closed -$1K – 1056
2015
Q4 		$1K Hold
118
– – ﹤0.01% 1002
2015
Q3 		$1K Hold
118
– – ﹤0.01% 980
2015
Q2 		$2K Hold
118
– – ﹤0.01% 883
2015
Q1 		$1K Hold
118
– – ﹤0.01% 1118
2014
Q4 		$1K Hold
118
– – ﹤0.01% 1130
2014
Q3 		$1K Hold
118
– – ﹤0.01% 1108
2014
Q2 		$2K Hold
118
– – ﹤0.01% 1029
2014
Q1 		$1K Buy
+118
New +$1.26K ﹤0.01% 1155

Other funds holding BCRX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Enterprise Financial Services Corp (EFSC)'s BCRX Position: Q1 2016 in Review

Enterprise Financial Services Corp (EFSC) sold out of BioCryst Pharmaceuticals (BCRX) in Q1 2016, closing a stake of 118 shares — an estimated $1K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in BCRX in Q1 2014 and held it in 8 quarters. The position peaked at $2K in Q2 2015. 109 funds tracked by Wall St. Rank hold BCRX as of Q1 2016.

  • Enterprise Financial Services Corp (EFSC) reported no remaining BioCryst Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Enterprise Financial Services Corp (EFSC) sold 118 BioCryst Pharmaceuticals shares in Q1 2016, an estimated $1K.
  • Enterprise Financial Services Corp (EFSC) first reported a position in BioCryst Pharmaceuticals in Q1 2014 and held it in 8 quarters.
  • Enterprise Financial Services Corp (EFSC)'s BioCryst Pharmaceuticals position peaked at $2K in Q2 2015.
  • 109 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q1 2016.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q1 2016, filed 29 Apr 2016.